Generics

Filter

Current filters:

None

Popular Filters

1051 to 1075 of 1158 results

New biologics and biosimilars approval guidelines in Mexico

04-05-2012

In Mexico, new guidelines are now in effect for the market authorization of biologics and biosimilars,…

BiotechnologyGenericsRegulationSouth America

Novartis to buy US generic derma company Fougera for over $1.5 billion

03-05-2012

Further expanding its generic drug foot print, Swiss drug giant Novartis (NOVN: VX) is adding to its…

DermatologicalsFougera PharmaceuticalsGenericsMergers & AcquisitionsNovartisPharmaceuticalSandoz

Ukraine to introduce reference pricing and plans for prescription system

01-05-2012

The Ukraine Ministry of Health and domestic producers of pharmaceuticals have signed a memorandum of…

EuropeGenericsHealthcarePharmaceuticalPricingRegulation

Watson 1st-qtr EPS rise of 84% beats analysts' forecasts

30-04-2012

US generic drugs major Watson Pharmaceuticals (NYSE: WPI) yesterday posted a very strong set of first-quarter…

FinancialGenericsWatson Pharmaceuticals

Access to low-price generics threatened by technologies due to be used in EU

30-04-2012

Producers of generic medicines are raising concerns on the huge cost implications of possible new anti-falsification…

EuropeGenericsRegulation

Global generic drug markets will grow to $221 billion by 2016; Espicom

29-04-2012

The economic recession has been a double-edged sword for the international generic drugs business. Driven…

GenericsGlobalMarkets & MarketingMergers & AcquisitionsPricing

Cancer drugs shortages persist in Poland

26-04-2012

In Poland, the recent procurement problems of cancer drugs is far from solved, writes Sebastian Gensior…

EuropeGenericsHealthcareNovartisOncologyPharmaceuticalPricingSandoz

Fitch puts Watson on rating watch Negative on planned acquisition of Actavis

26-04-2012

US generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has seen its rating downgraded by Fitch Ratings,…

ActavisFinancialGenericsMergers & AcquisitionsNorth AmericaWatson Pharmaceuticals

Watson Pharma confirms buy of generic group Actavis for 4.25 billion euros

26-04-2012

As has been widely rumoured over this week, Watson Pharmaceuticals (NYSE: WPI) has confirmed a definitive…

ActavisGenericsMergers & AcquisitionsWatson Pharmaceuticals

European austerity measures lead change in generic drug pricing

25-04-2012

Generic drugs are expected to help countries cope with health care cuts brought about by strict austerity…

EuropeGenericsHealthcarePharmaceuticalPricing

Novartis posts sharp drop in 1st-qtr profit; challenges UK off-label Avastin use

24-04-2012

Swiss drug major Novartis (NOVN: VX) has reported a sharp fall in first-quarter 2012 profits, due in…

AvastinEuropeFinancialGenericsLegalLucentisNovartisOphthalmicsPharmaceutical

Sandoz links with Cinpharm for generics in Sub-Saharan Africa

24-04-2012

Sandoz, the generics business of Swiss drug major Novartis (NOVN: VX), said yesterday that its German…

CinpharmGenericsMarkets & MarketingNovartisRest of the WorldSandoz

Stada Arz viewing optimization of Russian operations

23-04-2012

German pharmaceutical producer Stada Arzneimittel is considering optimizing its Russian operations through…

EuropeFinancialGenericsMarkets & MarketingPharmaceuticalSTADA Arzneimittel

Par Pharma acquires Handa's ANDA for generic Dexilant

23-04-2012

USA-based Par Pharmaceutical (NYSE: PRX) has entered into an exclusive acquisition and license agreement…

DexilantGastro-intestinalsGenericsHanda PharmaceuticalsLicensingNorth AmericaPar PharmaceuticalsTakeda Pharmaceuticals

Crucial need for global development of biosimilars, says head of European generics group

20-04-2012

"The need for a framework which allows global biosimilars development is now crucial," argued European…

BiotechnologyGenericsGlobalRegulation

Daiichi Sankyo and Ranbaxy launch Sevikar in Romania

19-04-2012

Japanese drug major Daiichi Sankyo (TYO: 4568) and its majority-owned Indian subsidiary Ranbaxy Laboratories…

Cardio-vascularDaiichi SankyoEuropeGenericsMarkets & MarketingPharmaceuticalRanbaxy LaboratoriesSevikar

Leahy Bill would boost generic drug safety in USA, says consumer group

19-04-2012

A bill giving generic drug manufacturers in the USA the authority to revise labeling for their products…

GenericsNorth AmericaPoliticsRegulation

Legislative changes to hamper near-term innovative drugs market in Central Europe

16-04-2012

Due to legislative changes implemented during 2011 in most of the Central European (CE) countries, the…

EuropeGenericsMarkets & MarketingPharmaceuticalPricingRegulation

1051 to 1075 of 1158 results

Back to top